Product Description
Vitamin C (ascorbic acid) is a nutrient your body needs to form blood vessels, cartilage, muscle and collagen in bones. Vitamin C is also vital to your body's healing process. (Sourced from: https://www.mayoclinic.org/drugs-supplements-vitamin-c/art-20363932)
Mechanisms of Action: Prolyl Hydroxylase Cofactor,Free Radical Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral,Intravenous
FDA Designation: None *
Approval Status: Approved
Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam
Approved Indications: Vitamin D Deficiency | Vitamin D Deficiency | Vitamin D Deficiency
Known Adverse Events: Diplopia | Dizziness | Headache | Erythema | Pruritus | Anaphylaxis | Angioedema | Urticaria | Edema
Company: Norgine
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: Australia, Belgium, Canada, China, Colombia, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Nepal, Netherlands, New Zealand, Pakistan, Portugal, Romania, Saudi Arabia, Serbia, Slovenia, Spain, Switzerland, United Kingdom, United States
Active Clinical Trial Count:
Highest Development Phases
Phase 3: Acute Respiratory Distress Syndrome|Anemia, Iron-Deficiency|COVID-19|Coronavirus Infections|Deficiency Diseases|Influenza, Human|Pneumonia|Sepsis
Phase 2: Adenocarcinoma|Cardiac Arrest|Cerebellar Ataxia|Colorectal Cancer|Herpes Zoster|Lung Cancer|Lymphoma|Pain Unspecified|Pancreatic Cancer|Prostate Cancer|Stem Cell Transplant|Tachycardia, Ventricular|Vaginosis, Bacterial|Ventricular Fibrillation
Phase 1: Acinar Cell Carcinoma|Anemia|Brain Cancer|Breast Cancer|Ductal Breast Carcinoma|Intermittent Claudication|Pancreatic Ductal Carcinoma|Peripheral Arterial Disease|Peripheral Vascular Diseases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| J21127 | P2 |
Recruiting |
Prostate Cancer |
2028-03-01 |
|
| FSJD-EnergiQ-2023 | P2 |
Unknown Status |
Cerebellar Ataxia |
2028-01-01 |
|
| The ACCURATE Study | P2 |
Unknown Status |
Unknown |
2026-12-31 |
|
| REMAP-CAP | P3 |
Recruiting |
COVID-19|Influenza, Human|Pneumonia |
2026-02-01 |